# A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily

> **NCT00417937** · PHASE4 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 98 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** azelaic acid 15% gel
- **DRUG:** azelaic acid 15% gel

## Key facts

- **NCT ID:** NCT00417937
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2023-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417937, "A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00417937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*